SG Americas Securities
GSK icon

SG Americas Securities’s GSK GSK Stock Holding History

SG Americas Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-158,400
Closed -$30K – 3394
2016
Q2 		$30K Buy
+158,400
New +$8.34M ﹤0.01% 2490

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SG Americas Securities's GSK Position: Q1 2026 in Review

SG Americas Securities reduced its GSK (GSK) stake by 51% in Q1 2026, selling an estimated $645K and leaving 11,363 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #2055.

SG Americas Securities first reported a position in GSK in Q1 2014 and has held it in 41 quarters since. The position peaked at $19.7M in Q2 2021. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • SG Americas Securities held 11,363 shares of GSK worth $627K as of Q1 2026.
  • SG Americas Securities sold 11,905 GSK shares in Q1 2026, an estimated $645K.
  • GSK made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2055 holding.
  • SG Americas Securities first reported a position in GSK in Q1 2014 and has held it in 41 quarters since.
  • SG Americas Securities's GSK position peaked at $19.7M in Q2 2021.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.